Skip to main content
SpringerLink
Log in

Prognostic Indicators and Treatment of IgA Nephropathy in China

  • Chapter
  • First Online:
Pathogenesis and Treatment in IgA Nephropathy

  • 779 Accesses

Abstract

IgA nephropathy (IgAN) accounts for 45 % of the primary glomerulonephritis in China. The 10- and 20-year cumulative renal survival rates were 83 % and 64 %, respectively, in a cohort of 1,155 Chinese patients with IgAN. The levels of estimated glomerular filtration rate (eGFR), proteinuria, hypoproteinemia, hypertension and hyperuricemia are the five most important clinical risk factors independently associated with renal outcome. Pathologically, the lesions of mesangial proliferation and tubular interstitial fibrosis correlated independently with prognosis of patients with IgAN. IgAN patients with minimal change disease and those with recurrent macro-hematuria are considered distinct subtypes of IgAN and have a relatively favorable renal prognosis. Using repeat renal biopsy data, we found that active proliferative lesions (glomerular endocapillary hypercellularity, crescent, or necrosis) are reversible after immunosuppressive treatment. The renal pathological lesion-based guidance for treatment options provides new tools for individual therapy in IgAN patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. D’Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol. 2004;24(3):179–96. doi:S0270929504000038 [pii].

    Article  PubMed  Google Scholar 

  2. Li LS, Liu ZH. Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies. Kidney Int. 2004;66(3):920–3. doi:10.1111/j.1523-1755.2004.00837.x.

    Article  PubMed  Google Scholar 

  3. Barbour SJ, Cattran DC, Kim SJ, Levin A, Wald R, Hladunewich MA, et al. Individuals of Pacific Asian origin with IgA nephropathy have an increased risk of progression to end-stage renal disease. Kidney Int. 2013;84(5):1017–24. doi:10.1038/ki.2013.210.

    Article  CAS  PubMed  Google Scholar 

  4. Coppo R, D’Amico G. Factors predicting progression of IgA nephropathies. J Nephrol. 2005;18(5):503–12.

    PubMed  Google Scholar 

  5. Le W, Liang S, Hu Y, Deng K, Bao H, Zeng C, et al. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population. Nephrol Dial Transplant. 2012;27(4):1479–85. doi:10.1093/ndt/gfr527.

    Article  CAS  PubMed  Google Scholar 

  6. Moriyama T, Tanaka K, Iwasaki C, Oshima Y, Ochi A, Kataoka H, et al. Prognosis in IgA nephropathy: 30-year analysis of 1,012 patients at a single center in Japan. PLoS One. 2014;9(3):e91756. doi:10.1371/journal.pone.0091756.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Lee H, Kim DK, Oh KH, Joo KW, Kim YS, Chae DW, et al. Mortality of IgA nephropathy patients: a single center experience over 30 years. PLoS One. 2012;7(12):e51225. doi:10.1371/journal.pone.0051225.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Gutierrez E, Zamora I, Ballarin JA, Arce Y, Jimenez S, Quereda C, et al. Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria. J Am Soc Nephrol. 2012;23(10):1753–60. doi:10.1681/ASN.2012010063.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Moreno JA, Martin-Cleary C, Gutierrez E, Rubio-Navarro A, Ortiz A, Praga M, et al. Haematuria: the forgotten CKD factor? Nephrol Dial Transplant. 2012;27(1):28–34. doi:10.1093/ndt/gfr749.

    Article  PubMed  Google Scholar 

  10. Le W, Liang S, Chen H, Wang S, Zhang W, Wang X, et al. Long-term outcome of IgA nephropathy patients with recurrent macroscopic hematuria. Am J Nephrol. 2014;40(1):43–50. doi:10.1159/000364954.

    Article  CAS  PubMed  Google Scholar 

  11. Eitner F, Floege J. In search of a better understanding of IgA nephropathy-associated hematuria. Kidney Int. 2012;82(5):513–5. doi:10.1038/ki.2012.160.

    Article  CAS  PubMed  Google Scholar 

  12. Lai KN, Lai FM, Ho CP, Chan KW. Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: a long-term controlled trial. Clin Nephrol. 1986;26(4):174–80.

    CAS  PubMed  Google Scholar 

  13. Roberts IS, Cook HT, Troyanov S, Alpers CE, Amore A, Barratt J, et al. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int. 2009;76(5):546–56. doi:10.1038/ki.2009.168.

    Article  PubMed  Google Scholar 

  14. Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009;76(5):534–45. doi:10.1038/ki.2009.243.

    Article  PubMed  Google Scholar 

  15. Roberts IS. Oxford classification of immunoglobulin A nephropathy: an update. Curr Opin Nephrol Hypertens. 2013. doi:10.1097/MNH.0b013e32835fe65c.

    PubMed  Google Scholar 

  16. Zeng CH, Le W, Ni Z, Zhang M, Miao L, Luo P, et al. A multicenter application and evaluation of the oxford classification of IgA nephropathy in adult Chinese patients. Am J Kidney Dis. 2012;60(5):812–20. doi:10.1053/j.ajkd.2012.06.011.

    Article  PubMed  Google Scholar 

  17. Shi SF, Wang SX, Jiang L, Lv JC, Liu LJ, Chen YQ, et al. Pathologic predictors of renal outcome and therapeutic efficacy in IgA nephropathy: validation of the oxford classification. Clin J Am Soc Nephrol. 2011;6(9):2175–84. doi:10.2215/CJN.11521210.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Le W, Zeng CH, Liu Z, Liu D, Yang Q, Lin RX, et al. Validation of the Oxford classification of IgA nephropathy for pediatric patients from China. BMC Nephrol. 2012;13:158. doi:10.1186/1471-2369-13-158.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Shen XH, Liang SS, Chen HM, Le WB, Jiang S, Zeng CH, et al. Reversal of active glomerular lesions after immunosuppressive therapy in patients with IgA nephropathy: a repeat-biopsy based observation. J Nephrol. 2015. doi:10.1007/s40620-014-0165-x.

    PubMed  Google Scholar 

  20. Wang J, Juan C, Huang Q, Zeng C, Liu Z. Corticosteroid therapy in IgA nephropathy with minimal change-like lesions: a single-centre cohort study. Nephrol Dial Transplant. 2013;28(9):2339–45. doi:10.1093/ndt/gft211.

    Article  CAS  PubMed  Google Scholar 

  21. Tang Z, Wu Y, Wang QW, Yu YS, Hu WX, Yao XD, et al. Idiopathic IgA nephropathy with diffuse crescent formation. Am J Nephrol. 2002;22(5–6):480–6. doi:ajn22480 [pii].

    Article  PubMed  Google Scholar 

  22. Lv J, Yang Y, Zhang H, Chen W, Pan X, Guo Z, et al. Prediction of outcomes in crescentic IgA nephropathy in a multicenter cohort study. J Am Soc Nephrol. 2013;24(12):2118–25. doi:10.1681/ASN.2012101017.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Conflict of Interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, No. 305, ZhongShan Road, Nanjing, China, 210018

    Wei-Bo Le & Zhi-Hong Liu

Authors
  1. Wei-Bo Le
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhi-Hong Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhi-Hong Liu .

Editor information

Editors and Affiliations

  1. Tokyo 113-8421, Tokyo, Japan

    Yasuhiko Tomino

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Japan

About this chapter

Cite this chapter

Le, WB., Liu, ZH. (2016). Prognostic Indicators and Treatment of IgA Nephropathy in China. In: Tomino, Y. (eds) Pathogenesis and Treatment in IgA Nephropathy. Springer, Tokyo. https://doi.org/10.1007/978-4-431-55588-9_9

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-55588-9_9

  • Published:

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-55587-2

  • Online ISBN: 978-4-431-55588-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation